不确定的潜力和免疫性血小板缺血的风险的克隆性血液形成
Qianwei Liu1,2, Tove Wästerlid3, Karin E Smedby3
1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Journal of internal medicine
|April 30, 2025
概括
具有不确定潜力的克隆性血液形成 (CHIP) 个体面临显著更高的发展免疫血栓塞缩症 (ITP) 的风险. 这种增加的风险在涉及JAK2或SRSF2突变的情况下尤为明显.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 是一种特定基因突变导致某些血细胞过度生产的疾病.
- CHIP可能会影响免疫功能和血小板的产生,可能与免疫性血小板缺血 (ITP) 联系起来.
- 在CHIP患者中,患有ITP的确切风险在很大程度上仍未确定.
研究的目的:
- 确定CHIP与随后发展ITP的风险之间的关联.
- 识别可能导致ITP风险更高的特定CHIP突变.
主要方法:
- 一项前性队列研究利用英国生物库数据从466,064名参与者 (2006-2022).
- 通过整体外基因组测序来确定CHIP状态.
- 事件ITP病例通过医院记录和死亡登记册被确定.
- 考克斯回归模型用于评估ITP风险,并对常见的CHIP突变 (DNMT3A,TET2,ASXL1,SRSF2,JAK2) 进行亚组分析.
主要成果:
- 这项研究包括14466名CHIP患者和451598名没有CHIP患者.
- CHIP与ITP的风险增加了2.33倍 (HR为2.33,95% CI为1.64-3.32).
- 在CHIP中观察到JAK2 (HR 54.31) 和SRSF2 (HR 20.11) 突变的ITP风险最高,其次是TET2 (HR 4.00) 和DNMT3A (HR 1.95) 突变.
结论:
- CHIP显著增加了ITP诊断的风险.
- 在CHIP中具有JAK2或SRSF2突变的个体具有明显增加的ITP风险.
- 在被诊断为CHIP的患者中,对ITP进行临床警是有必要的.
相关概念视频
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:23Cells of the Adaptive Immune Response
738
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
738
01:34Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
01:21Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K